101 related articles for article (PubMed ID: 17613595)
1. An association study of two functional promotor polymorphisms in the myeloperoxidase (MPO) gene in multiple sclerosis.
Lundmark F; Salter H; Hillert J
Mult Scler; 2007 Jul; 13(6):697-700. PubMed ID: 17613595
[TBL] [Abstract][Full Text] [Related]
2. Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis?
Sidoti A; Antognelli C; Rinaldi C; D'Angelo R; Dattola V; Girlanda P; Talesa V; Amato A
Mult Scler; 2007 May; 13(4):446-53. PubMed ID: 17463067
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in the myeloperoxidase gene and cognitive impairment in multiple sclerosis.
Manna I; Valentino P; La Russa A; Condino F; Nisticò R; Liguori M; Clodomiro A; Andreoli V; Pirritano D; Cittadella R; Quattrone A
J Negat Results Biomed; 2006 Feb; 5():3. PubMed ID: 16504169
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation of myeloperoxidase gene contributes to atopic asthma susceptibility: a preliminary association study in Russian population.
Polonikov AV; Solodilova MA; Ivanov VP
J Asthma; 2009 Jun; 46(5):523-8. PubMed ID: 19544176
[TBL] [Abstract][Full Text] [Related]
5. Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms.
Hoy A; Trégouët D; Leininger-Muller B; Poirier O; Maurice M; Sass C; Siest G; Tiret L; Visvikis S
Eur J Hum Genet; 2001 Oct; 9(10):780-6. PubMed ID: 11781690
[TBL] [Abstract][Full Text] [Related]
6. PAI and TPA gene polymorphisms in multiple sclerosis.
Lovrecic L; Ristić S; Starcević-Cizmarević N; Brajenović-Milić B; Jazbec SS; Sepcić J; Kapović M; Peterlin B
Mult Scler; 2008 Mar; 14(2):243-7. PubMed ID: 17986506
[TBL] [Abstract][Full Text] [Related]
7. COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of -765G>C with disease risk.
Mazzola S; Lira MG; Benedetti MD; Salviati A; Ottaviani S; Malerba G; Ortombina M; Pignatti PF
Int J Immunogenet; 2007 Apr; 34(2):71-4. PubMed ID: 17373929
[TBL] [Abstract][Full Text] [Related]
8. The role of the polio virus receptor and the herpesvirus entry mediator B genes for the development of MS.
Rosche B; Cepok S; Stei S; Vogel F; Grummel V; Hoffmann S; Kroner A; Mäurer M; Rieckmann P; Sommer N; Hemmer B
J Neuroimmunol; 2004 Nov; 156(1-2):171-7. PubMed ID: 15465608
[TBL] [Abstract][Full Text] [Related]
9. Association of the MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia.
Djurić T; Zivković M; Stanković A; Dincić E; Raicević R; Alavantić D
J Neurol Sci; 2008 Apr; 267(1-2):62-5. PubMed ID: 17942123
[TBL] [Abstract][Full Text] [Related]
10. The myeloperoxidase gene and its influence on myocardial infarction in a Swedish population: protective role of the -129A allele in women.
Zotova E; Lyrenäs L; de Faire U; Morgenstern R; Gigante B; Bennet AM
Coron Artery Dis; 2009 Aug; 20(5):322-6. PubMed ID: 19543083
[TBL] [Abstract][Full Text] [Related]
11. The 795CT polymorphism in osteopontin gene is not associated with multiple sclerosis in a Spanish population.
Mas A; Martínez A; de las Heras V; Bartolomé M; de la Concha EG; Arroyo R; Urcelay E
Mult Scler; 2007 Mar; 13(2):250-2. PubMed ID: 17439891
[TBL] [Abstract][Full Text] [Related]
12. Analysis of myeloperoxidase promotor polymorphism and enzyme activity in Turkish patients with vitiligo.
Aksoy SN; Erbagci Z; Saygili EI; Sever T; Erbagci AB; Pehlivan S
Eur J Dermatol; 2009; 19(6):576-80. PubMed ID: 19758957
[TBL] [Abstract][Full Text] [Related]
13. The role of VLA4 polymorphisms in multiple sclerosis: an association study.
Andreoli V; Cittadella R; Valentino P; Condino F; La Russa A; Liguori M; Manna I; Spadafora P; Nisticò R; Pirritano D; Clodomiro A; Quattrone A
J Neuroimmunol; 2007 Sep; 189(1-2):125-8. PubMed ID: 17609118
[TBL] [Abstract][Full Text] [Related]
14. T-1237C polymorphism of TLR9 gene is not associated with multiple sclerosis in the Portuguese population.
Carvalho A; Santos M; Maciel P; Rodrigues F
Mult Scler; 2008 May; 14(4):550-2. PubMed ID: 18208876
[TBL] [Abstract][Full Text] [Related]
15. The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes.
Mäkelä R; Loimaala A; Nenonen A; Mercuri M; Vuori I; Huhtala H; Oja P; Bond G; Koivula T; Lehtimäki T
Clin Biochem; 2008 May; 41(7-8):532-7. PubMed ID: 18280811
[TBL] [Abstract][Full Text] [Related]
16. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.
Lundmark F; Duvefelt K; Iacobaeus E; Kockum I; Wallström E; Khademi M; Oturai A; Ryder LP; Saarela J; Harbo HF; Celius EG; Salter H; Olsson T; Hillert J
Nat Genet; 2007 Sep; 39(9):1108-13. PubMed ID: 17660816
[TBL] [Abstract][Full Text] [Related]
17. FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity?
Martínez A; Mas A; de Las Heras V; Bartolomé M; Arroyo R; Fernández-Arquero M; de la Concha EG; Urcelay E
J Neuroimmunol; 2007 Sep; 189(1-2):132-6. PubMed ID: 17617473
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 and multiple sclerosis: the A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population.
Wray BN; Stankovich J; Whittock L; Dwyer T; Ponsonby AL; van der Mei IA; Taylor B; Dickinson J; Foote S; McMorran BJ
J Neuroimmunol; 2008 May; 196(1-2):139-42. PubMed ID: 18378005
[TBL] [Abstract][Full Text] [Related]
19. Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis.
Zakrzewska-Pniewska B; Styczynska M; Podlecka A; Samocka R; Peplonska B; Barcikowska M; Kwiecinski H
Mult Scler; 2004 Jun; 10(3):266-71. PubMed ID: 15222689
[TBL] [Abstract][Full Text] [Related]
20. Sex specifically associated promoter polymorphism in multiple sclerosis affects interleukin 4 expression levels.
Akkad DA; Arning L; Ibrahim SM; Epplen JT
Genes Immun; 2007 Dec; 8(8):703-6. PubMed ID: 17855802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
